Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Johnson & Johnson (JNJ) Com Stk USD 1 (CDI)

Sell:$142.49 Buy:$142.50 Change: $0.12 (0.08%)
Market closed |  Prices as at close on 10 July 2020 | Switch to live prices |
Change: $0.12 (0.08%)
Market closed |  Prices as at close on 10 July 2020 | Switch to live prices |
Change: $0.12 (0.08%)
Market closed |  Prices as at close on 10 July 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Contact details

1 Johnson And Johnson Plz
United States
+1 (732) 5242455

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$377.46 billion
Shares in issue:
2.63 billion
New York Stock Exchange
United States
US dollar
Dow Jones Industrial Average

Key personnel

  • Alex Gorsky
    Chairman of the Board, Chief Executive Officer
  • Paulus Stoffels
    Vice Chairman- Executive Committee, Chief Scientific Officer
  • Joaquin Duato
    Vice Chairman - Executive Committee
  • Joseph Wolk
    Chief Financial Officer, Executive Vice President
  • Peter Fasolo
    Chief Human Resource Officer, Executive Vice President
  • Michael Ullmann
    Executive Vice President, General Counsel
  • Ashley McEvoy
    Executive Vice President - Worldwide Chairman, Medical Devices
  • Thibaut Mongon
    Executive Vice President, Worldwide Chairman, Consumer
  • Michael Sneed
    Executive Vice President - Global Corporate Affairs and Chief Communication Officer
  • Jennifer Taubert
    Executive Vice President - Worldwide Chairman, Pharmaceuticals

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.